3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Hemangiosarcoma
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms
1
Interventions
Paclitaxel
16
pembrolizumab
15
Carboplatin
13
Specimen Handling
9
Magnetic Resonance Spectroscopy
8
Biopsy
7
Bevacizumab
7
Fulvestrant
6
olaparib
5
Taxes
5
Megestrol Acetate
5
Doxorubicin
5
Cisplatin
5
trastuzumab deruxtecan
4
dostarlimab
4
Nivolumab
4
Gemcitabine
4
palbociclib
3
durvalumab
3
Progestins
3
Oxaliplatin
3
Medroxyprogesterone Acetate
3
Leucovorin
3
Letrozole
3
Immunoglobulin G
3
Fluorouracil
3
Docetaxel
3
Disulfides
3
ribociclib
2
pertuzumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
4-hydroxy-N-desmethyltamoxifen
×
30 days
×
Clear all
No trials found.